Browse Drug Recalls

392 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 392 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 392 FDA drug recalls.

Clear
DateProductReasonClassFirm
May 10, 2017 Divalproex Sodium Delayed Release Tablets, USP, 250 mg 100-count bottle (NDC ... Failed Dissolution Specifications Class II Zydus Pharmaceuticals USA Inc
Mar 15, 2017 Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a) 100 count (NDC 68... Failed Dissolution Specifications; 9 month long term stability Class II Zydus Pharmaceuticals USA Inc
Mar 13, 2017 Sulfamethoxazole and Trimethoprim Oral Suspension, USP 200 mg / 40 mg per 5 m... Failed Dissolution Specifications Class II Akorn Inc
Mar 7, 2017 Quillivant XR (methylphenidate HCl) for extended-release oral suspension, 900... Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at ... Class III Pfizer Inc
Mar 7, 2017 Quillivant XR (methylphenidate HCl) for extended-release oral suspension, 300... Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at ... Class III Pfizer Inc
Mar 7, 2017 Quillivant XR (methylphenidate HCl) for extended-release oral suspension, 750... Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at ... Class III Pfizer Inc
Feb 17, 2017 Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per ... Failed Dissolution Specifications: low out of specification dissolution results found during stab... Class III Teva Pharmaceuticals USA
Feb 15, 2017 Zenatane (isotretinoin) capsules, 20 mg, packaged in 30-count cartons (3 x 1... Failed dissolution specifications - low dissolution results at S3 stage. Class III Dr. Reddy's Laboratories, Inc.
Feb 15, 2017 Zenatane (isotretinoin) capsules, 40 mg, packaged in 30-count cartons (3 x 1... Failed dissolution specifications - low dissolution results at S3 stage. Class III Dr. Reddy's Laboratories, Inc.
Feb 15, 2017 Zenatane (isotretinoin) capsules, 30 mg, packaged in 30-count cartons (3 x 1... Failed dissolution specifications - low dissolution results at S3 stage. Class III Dr. Reddy's Laboratories, Inc.
Feb 15, 2017 Zenatane (isotretinoin) capsules, 10 mg, packaged in 30-count cartons (3 x 1... Failed dissolution specifications - low dissolution results at S3 stage. Class III Dr. Reddy's Laboratories, Inc.
Feb 10, 2017 Pioglitazone and Glimepiride Tablets, USP, 30 mg/4 mg, 30 count bottles, Rx o... Failed Dissolution Specifications Class II Sandoz Inc
Feb 7, 2017 Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsi... Failed Dissolution Specifications Class II RemedyRepack Inc.
Feb 3, 2017 GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21... Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specificati... Class II Amerisource Health Services
Jan 30, 2017 Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufa... Failed Dissolution Specifications. Above out of specification for dissolution rate observed at th... Class II Actavis Inc
Jan 12, 2017 Sun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottl... Failed Dissolution Specifications Class II Sun Pharmaceutical Industries, Inc.
Jan 5, 2017 Fluconazole Tablets, USP, 100 mg, 100-count Unit Dose carton, Rx only, Manufa... Failed Dissolution Specifications Class II The Harvard Drug Group
Jan 5, 2017 Fluconazole Tablets, USP, 200 mg, 100-count Unit Dose carton, Rx only, Manufa... Failed Dissolution Specifications Class II The Harvard Drug Group
Dec 28, 2016 Flucanozole Tablets, USP, 200 mg, a) 30 count (NDC 55111-146-30) and b) 100 c... Failed Dissolution Specifications; 18 month stability time point Class II Dr. Reddy's Laboratories, Inc.
Dec 28, 2016 Flucanozole Tablets, USP, 100 mg, a) 30 count (NDC 55111-144-30) and b) 100 c... Failed Dissolution Specifications; 18 month stability time point Class II Dr. Reddy's Laboratories, Inc.
Dec 28, 2016 Flucanozole Tablets, USP, 50 mg, a) 30 count (NDC 55111-143-30) and b) 100 co... Failed Dissolution Specifications; 18 month stability time point Class II Dr. Reddy's Laboratories, Inc.
Dec 28, 2016 Flucanozole Tablets, USP, 150 mg, 12x1 Blister cards, Rx Only, Mfd. by: Dr. R... Failed Dissolution Specifications; 18 month stability time point Class II Dr. Reddy's Laboratories, Inc.
Dec 22, 2016 Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactu... Failed dissolution specification: recalled due to an out of specification dissolution result of 4... Class II Sandoz Incorporated
Dec 20, 2016 buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count ... Failed Dissolution Specifications; 18 month stability time point Class III Sun Pharmaceutical Industries, Inc.
Dec 20, 2016 buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 (ND... Failed Dissolution Specifications; 18 month stability time point Class III Sun Pharmaceutical Industries, Inc.
Dec 12, 2016 Rabeprazole Sodium Delayed Release Tablets, 20 mg, a) 30-count bottle (NDC 65... Failed Dissolution Specifications Class II Amneal Pharmaceuticals LLC
Dec 1, 2016 Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per ... Failed Dissolution Specifications Class III Teva Pharmaceuticals USA
Nov 2, 2016 BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, Rx Only, a) 3... Failed Dissolution Specifications; 6 month time point Class III Zydus Pharmaceuticals USA Inc
Oct 27, 2016 Bupropion Hydrochloride Extended-Release Tablets, USP (XL), 300 mg, a) 90-co... Failed Dissolution Specifications: The firm was notified that there was a dissolution out of spec... Class III Amerisource Health Services
Oct 3, 2016 Phenobarbital Tablets, USP 60mg 100=count bottles, Rx Only, Mfd. by: West-War... Failed Dissolution Specifications: Phenobarbital Tablets have an out of specification for dissolu... Class II West-Ward Pharmaceuticals Corp.
Sep 13, 2016 buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-D... Failed Dissolution Specifications Class III Sun Pharmaceutical Industries, Inc.
Aug 29, 2016 ZENATANE (isotretinoin capsules USP) 20 mg, 30 capsules per prescription pack... Failed Dissolution Specifications Class III Dr. Reddy's Laboratories, Inc.
Aug 23, 2016 Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: ... Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out... Class III Stason Pharmaceuticals, Inc.
Aug 4, 2016 buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count ... Failed dissolution specifications - the out of specification result for dissolution was identifie... Class III Amerisource Health Services
Aug 3, 2016 BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, ... Failed Dissolution Specifications: Product did not meet dissolution specification at an intermedi... Class III Zydus Pharmaceuticals USA Inc
Aug 3, 2016 Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per ... Failed Dissolution Specifications: Out-of-specification results in retained sample. Class II Golden State Medical Supply Inc.
Aug 3, 2016 Venlafaxine Hydrochloride Extended-Release Capsules, 150 mg, a) 30 capsules p... Failed Dissolution Specifications: Out-of-specification results in retained sample. Class II Golden State Medical Supply Inc.
Jul 19, 2016 Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68... Failed Dissolution Specifications: out of specification dissolution results in retained samples Class II Zydus Pharmaceuticals USA Inc
Jul 19, 2016 Venlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 6... Failed Dissolution Specifications: out of specification dissolution results in retained samples Class II Zydus Pharmaceuticals USA Inc
Jul 11, 2016 Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles... Failed Dissolution Specifications Class II Actavis Inc
Jun 30, 2016 Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufact... Failed Dissolution Specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specificati... Class II Actavis Inc
Jun 27, 2016 buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 t... Failed Dissolution Specifications Class III Sun Pharmaceutical Industries, Inc.
Jun 22, 2016 Alprazolam Extended-release Tablets, USP, 1 mg, 60-count bottle, Rx Only, Ma... Failed Dissolution Specifications Class II Mylan Pharmaceuticals Inc.
May 23, 2016 Nitrofurantoin Oral Suspension, USP, 25 mg/5 mL, FOR ORAL USE ONLY, URINARY T... Failed Dissolution Specifications Class II Nostrum Laboratories, Inc.
Mar 31, 2016 Intermezzo (zolpidem tartrate) sublingual tablet 1.75 mg, CIV, 30 Ct Cartons,... Failed Dissolution Specifications Class III Purdue Pharma L.P.
Feb 12, 2016 Paliperidone Extended-release Tablets, 1.5 mg, 30 count bottles, Rx only, Myl... Failed Dissolution Specifications; three month stability time point. Class II Mylan Pharmaceuticals Inc.
Jan 26, 2016 Duloxetine Delayed-Release Capsules, USP, 30 mg, 30-count bottles, Rx only, M... Failed Dissolution Specification: Out of specification dissolution results when testing product s... Class III Apotex Scientific, Inc
Jan 26, 2016 Duloxetine Delayed-Release Capsules, USP, 20 mg, 60-count bottles, Rx only, M... Failed Dissolution Specification: Out of specification dissolution results when testing product s... Class III Apotex Scientific, Inc
Jan 26, 2016 Duloxetine Delayed-Release Capsules, USP, 60 mg, 30-count bottles, Rx only, M... Failed Dissolution Specification: Out of specification dissolution results when testing product s... Class III Apotex Scientific, Inc
Jan 18, 2016 Levofloxacin Tablets USP, 500 mg, packaged in 100-count (10 x 10) blister car... Failed Dissolution Specifications: Unexplained low out of specification results for dissolution. Class II Amerisource Health Services

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.